Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Stem cells and beta cell replacement therapy: a prospective health technology assessment study

Fig. 3

Expected value of perfect information results. Displayed are results of the value of further research for the scenarios using adherent (top) and suspension (bottom) cell culture techniques. All values are per patient calculations for willingness-to-pay thresholds of up to $200,000 per additional QALY. One can see the different values between cell culture techniques and between production scenarios within each technique. The dotted lines represent scenarios presuming an 80% increase of costs due to additional regulatory requirements compared to regulations currently in place. Scenarios Adh 20 and Sus 20 use a 0% discount rate

Back to article page